Patients with high nuclear Tak1 and low Cyld expression in HCC tissue showed significantly shorter overall survival, whereas vice versa, low nuclear Tak1 and high Cyld expression predicted longer survival times. This evidence concerns the gene CYLD and hepatocellular carcinoma.